Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Olsen

Showing results (971-980 of 1,260) with videos related to

Pageof 126
Sort By:
ESC Heart Failure|October 13, 2020
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular diseaseJohn Molvin, Amra Jujić, Olle Melander, et al.
Applied and Environmental Microbiology|December 1, 1992
Gene probe analysis of soil microbial populations selected by amendment with 2,4-dichlorophenoxyacetic acidW E Holben, B M Schroeter, V G Calabrese, et al.
Journal of Human Hypertension|April 16, 2004
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudyM H Olsen, K Wachtell, J N Bella, et al.
BMJ (Clinical Research Ed.)|April 18, 1992
Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testingS C Darby, J H Olsen, R Doll, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 2005
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndromeMichael H Olsen, Tine W Hansen, Marina K Christensen, et al.
Journal of Hypertension|March 15, 2006
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factorsMichael H Olsen, Marina K Christensen, Tine W Hansen, et al.
Circulation|July 10, 2002
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) StudyKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
Journal of Human Hypertension|May 4, 2007
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE studyG de Simone, M H Olsen, K Wachtell, et al.
The American Journal of Cardiology|November 22, 2020
Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic StenosisEmilie Ramberg, Anders M Greve, Ronan M G Berg, et al.
Scientific Reports|January 24, 2019
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive ProjectJohn Molvin, Manan Pareek, Amra Jujic, et al.
Pageof 126

Showing results (971-980 of 1,260) with videos related to

Sort By:
Pageof 126
ESC Heart Failure|October 13, 2020
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular diseaseJohn Molvin, Amra Jujić, Olle Melander, et al.
Applied and Environmental Microbiology|December 1, 1992
Gene probe analysis of soil microbial populations selected by amendment with 2,4-dichlorophenoxyacetic acidW E Holben, B M Schroeter, V G Calabrese, et al.
Journal of Human Hypertension|April 16, 2004
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudyM H Olsen, K Wachtell, J N Bella, et al.
BMJ (Clinical Research Ed.)|April 18, 1992
Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testingS C Darby, J H Olsen, R Doll, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 2005
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndromeMichael H Olsen, Tine W Hansen, Marina K Christensen, et al.
Journal of Hypertension|March 15, 2006
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factorsMichael H Olsen, Marina K Christensen, Tine W Hansen, et al.
Circulation|July 10, 2002
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) StudyKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
Journal of Human Hypertension|May 4, 2007
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE studyG de Simone, M H Olsen, K Wachtell, et al.
The American Journal of Cardiology|November 22, 2020
Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic StenosisEmilie Ramberg, Anders M Greve, Ronan M G Berg, et al.
Scientific Reports|January 24, 2019
Using a Targeted Proteomics Chip to Explore Pathophysiological Pathways for Incident Diabetes- The Malmö Preventive ProjectJohn Molvin, Manan Pareek, Amra Jujic, et al.
Pageof 126